Zdorovʹe Rebenka (Sep 2014)

Drugs Modulating TLR Activity

  • A.Ye. Abaturov,
  • A.P. Volosovets,
  • Ye.I. Yulish

DOI
https://doi.org/10.22141/2224-0551.6.57.2014.75743
Journal volume & issue
Vol. 9, no. 6.57
pp. 131 – 136

Abstract

Read online

The review presents characteristics of drugs being developed that modulate Toll-like receptors activity and can be applied in the treatment of infectious, chronic inflammatory, autoimmune, allergic diseases, malignancies.

Keywords